Items where authors include "Cacciapaglia, F."
Article
De Lorenzis, E., Natalello, G., Pellegrino, G. et al. (29 more authors) (2024) Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life. Rheumatology. keae532. ISSN 1462-0324
Deibel, E. orcid.org/0000-0003-4652-9826, Carreira, P.E., Vonk, M. orcid.org/0000-0002-2266-9907 et al. (61 more authors) (2024) Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time? Arthritis Care & Research, 76 (1). pp. 88-97. ISSN 2151-464X
Kuster, S., Jordan, S., Elhai, M. et al. (104 more authors) (2022) Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. RMD Open, 8 (2). e002477. ISSN 2056-5933
Conference or Workshop Item
Verardi, L., De Lorenzis, E., Pellegrino, G. et al. (19 more authors) (2023) POS1324 mycophenolate mofetil use in clinical practice in a multicentric cohort of scleroderma patients: persistence on therapy and long-term adverse events. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.